Technology tackles organ disease

Precision engineering has a long heritage in Switzerland, and these skills are now being used to tackle one of the biggest global health challenges – organ disease.

Bern-based company CAScinatrion has created a way of allowing surgeons to operate on the liver without causing unnecessary damage to healthy tissue.

Meanwhile, tissue engineering technology pioneered by Xeltis uses stem cells taken from the patient’s own bone marrow, to make new heart valves.

Adam Shaw reports.

If you would like to comment on this story or anything else you have seen on Future, head over to our Facebook page or message us on Twitter.